Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease-Reference-Cited by-同舟云学术

Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease

Published:2017-08 Issue:4 Volume:10 Page:699-706
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Prabhu Jyothi S,Korlimarla Aruna,Anupama C E,Alexander Annie,Raghavan Rohini,Kaul Roma,Desai Krisha,Rajarajan Savitha,Manjunath Suraj,Correa Marjorrie,Raman R,Kalamdani Anjali,Prasad MSN,Patil Shekar,Gopinath K S,Srinath B S,Sridhar T.S.

Funder

Nadathur Estates Private Ltd., Bangalore, India

The Bagaria Education Trust, Bangalore, India

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer;Harvey;J Clin Oncol,1999

2. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies;Blows;PLoS Med,2010

3. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study;Carey;JAMA,2006

4. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial;Albain;Lancet Oncol,2010

5. Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidating the Role of MicroRNA-18a in Propelling a Hybrid Epithelial–Mesenchymal Phenotype and Driving Malignant Progression in ER-Negative Breast Cancer;Cells;2024-05-10

2. An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancers;Translational Oncology;2023-11

3. Androgen Receptor driven gene score identifies tumors with Epithelial to Mesenchymal Transition features in triple negative breast cancer;2023-02-21

4. Cell State Transitions and Phenotypic Heterogeneity in Luminal Breast Cancer Implicating MicroRNAs as Potential Regulators;International Journal of Molecular Sciences;2023-02-09

5. Acquisition of hybrid E/M phenotype associated with increased migration, drug resistance and stemness is mediated by reduced miR-18a levels in ER-negative breast cancer;2022-09-06